Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 180 results found. Search for [ India vaccine candidates ]

Results 1 to 21 of 180
Reuters
September 18, 2020
In recent weeks, Pfizer has said it should know by the end of October whether the vaccine, developed together with Germany's BioNTech SE, is safe and effective


BusinessToday.In
September 18, 2020
Kirill Dmitriev, CEO of Russia's sovereign wealth fund Russian Direct Investment Fund, says India will play a vital role in fighting Covid-19 and that government's Make in India initiative has made pharma sector stronger


Reuters
September 18, 2020
The decision by one of the U.N. agency's biggest supporters is a big blow to its strategy aimed at uniting governments around the world to fight the coronavirus pandemic together


BusinessToday.In
September 17, 2020
Addressing the Rajya Sabha over the coronavirus situation in the country, Dr. Harsh Vardhan said that India is also making efforts like other nations, adding that \"three vaccine candidates are in different phases\" of clinical trials


BusinessToday.In
September 16, 2020
Coronavirus vaccine trials: While China has four vaccine candidates in third or final stages of clinical trials, there are at least two companies from the United States and one from UK and Germany, which are planning to rollout vaccine before December, if everything goes as per the plan


BusinessToday.In
September 16, 2020
Besides, the drug regulating body of the country has told the Serum Institute to take extra care during screening, provide additional information in informed consent, and closely monitor participants for any adverse events during follow-up of the study


BusinessToday.In
September 15, 2020
COVID-19 vaccine candidates being developed by Cadila Healthcare and Bharat Biotech have completed the phase one of the study while Pune-based Serum Institute of India (SII) will begin with Phase 3 clinical trial after getting regulatory nod, says ICMR chief


BusinessToday.In
September 14, 2020
Catch top stories from the world of business and economy with BusinessToday.In's Biz EOD report


Joe C Mathew
September 14, 2020
Stating that an effective vaccine would be the sure shot tool in containing COVID-19, Dr Vardhan said more than 30 vaccine candidates are in different stages of development in India


BusinessToday.In
September 13, 2020
Union Health Minister Harsh Vardhan on Sunday said that he will be the first person to take COVID-19 vaccine so as to dispel the \"trust deficit\" around the same


BusinessToday.In
September 13, 2020
Pfizer says trial is event-based and there are many variables that will ultimately impact read-out timing; adds if trials are successful, these companies would submit vaccines for approval as early as October


BusinessToday.In
September 12, 2020
Bharat Biotech says its vaccine candidate was found to generate \"robust immune responses\", thus preventing infection and disease in primates upon high amounts of exposure to live SARS-CoV-2 virus


BusinessToday.In
September 11, 2020
Another leading candidate for coronavirus vaccine is Moderna. The company said that it is talking to multiple countries for the rollout of the COVID-19 vaccine.


Rajeev Dubey & Manoj Sharma
September 9, 2020
\"AstraZeneca has paused the trials due to some unrelated issue with a patient in the UK, and we'll have to wait for AstraZeneca to explain what happened but this is not vaccine-related,\" says Poonawalla


PTI
September 9, 2020
The CP therapy involves taking antibodies from the blood of a person who has recovered from COVID-19 and transfusing those into an active coronavirus patient to help kickstart the immune system to fight the infection


BusinessToday.In
September 9, 2020
AstraZeneca said that an adverse reaction was observed in one of the volunteers in the UK. According to the pharmaceutical firm, the nature of the adverse reaction remained unknown, though the participant is expected to recover


BusinessToday.In
September 9, 2020
Dr VK Paul informed the Russian government has approached India to facilitate the Phase-3 trial of their vaccine and also manufacture Sputnik V through Indian companies


BusinessToday.In
September 8, 2020
On 11 August, the world's first vaccine against the COVID-19 'Sputnik V' was registered by the Russian government. The vaccine is developed by  Gamaleya National Research Center of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF)


BusinessToday.In
New Delhi, September 7, 2020
While most countries are in different stages of trials with regard to their potential COVID-19 vaccine candidates, Russia is all set to roll out its newly developed vaccine Sputnik V for civilian use this week; Delhi Metro has resumed services in three stages from Sept. 7 after a hiatus of over five months due to the Covid-19 pandemic, but stations in containment zones would remain closed; Banks may restructure loans of more than Rs 10 lakh crore largely attributed to 5-6 critical sectors, including aviation, commercial real estate and hospitality, that have been severely hit by the COVID-19 outbreak Watch this and more news on News Blast.Also Read: Vodafone Idea share rises 10% after board clears plan to raise Rs 25,000 crore


BusinessToday.In
New Delhi, September 7, 2020
Delhi Metro to resume in 3 stages, stations in containment zones to remain shutDelhi Metro is set to resume services in three stages from Sept. 7 after a hiatus of over five months due to the Covid-19 pandemic, but stations in containment zones would remain closed, DMRC said. Officials of the urban transporter also cautioned that \"trains may not stop at some of the stations\" if social distancing norms are not adhered to by the passengers.Transfer cash to poor, give free food, borrow more ...


PAGES 1 OF 9  12345